lumateperone 10.5 MG Oral Capsule

Managing this medication for someone you care for? Eleplan keeps diagnoses, medications and appointments in one plan.

Start free with Eleplan

Clinical drug

lumateperone 10.5 MG Oral Capsule

10.5 MG · Oral Capsule · oral

A form of lumateperone →

lumateperone 10.5 MG Oral Capsule — Butyrophenone derivatives. Strength, form, class, interactions & more.

lumateperone 10.5 MG Oral Capsule

Active ingredient

Classification

Butyrophenone derivativesAtypical Antipsychotic

Drug interactions

Lumateperone has clinically important interactions with CYP3A4 inducers and inhibitors, as well as serotonin reuptake inhibitors.

  • majorCYP3A4 inducers — decreases the exposure of lumateperone
  • moderatestrong CYP3A4 inhibitors — increases lumateperone exposure
  • moderatemoderate CYP3A4 inhibitors — increases lumateperone exposure
  • moderateserotonin reuptake inhibitors — increased risk of SRI-associated adverse reactions

Source: RxNorm + openFDA + RxClass + FAERS · 2026

Look up another medication

Powered by Eleplan

A drug lookup is just the start. Eleplan keeps the whole care plan in one place.

Medications, diagnoses, documents, appointments, and the whole care team — organized and always in sync, with Ellie, your AI care assistant, on top of it. Free to start.